NCT01394263View on ClinicalTrials.gov

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2003

Conditions
Prostate CancerAdenocarcinoma of the Prostate
Interventions
DRUG

Histrelin hydrogel implant

50 mg histrelin acetate in hyrogel implant

DRUG

Zoladex goserelin implant

goserelin implant injection.

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY